FI56623B - Saett att framstaella oralt intagbara medicinformer med foerlaengd verkan - Google Patents

Saett att framstaella oralt intagbara medicinformer med foerlaengd verkan

Info

Publication number
FI56623B
FI56623B FI1506/73A FI150673A FI56623B FI 56623 B FI56623 B FI 56623B FI 1506/73 A FI1506/73 A FI 1506/73A FI 150673 A FI150673 A FI 150673A FI 56623 B FI56623 B FI 56623B
Authority
FI
Finland
Prior art keywords
oralt
medicinformer
intagbara
foerlaengd
verkan
Prior art date
Application number
FI1506/73A
Other languages
English (en)
Other versions
FI56623C (fi
Inventor
Claude Mony
Genevieve Costes
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of FI56623B publication Critical patent/FI56623B/fi
Application granted granted Critical
Publication of FI56623C publication Critical patent/FI56623C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
FI1506/73A 1972-05-10 1973-05-10 Saett att framstaella oralt intagbara medicinformer med foerlaengd verkan FI56623C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7216616 1972-05-10
FR7216616A FR2183546B1 (fi) 1972-05-10 1972-05-10

Publications (2)

Publication Number Publication Date
FI56623B true FI56623B (fi) 1979-11-30
FI56623C FI56623C (fi) 1980-03-10

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1506/73A FI56623C (fi) 1972-05-10 1973-05-10 Saett att framstaella oralt intagbara medicinformer med foerlaengd verkan

Country Status (17)

Country Link
US (1) US3950508A (fi)
JP (1) JPS5526124B2 (fi)
AR (1) AR203268A1 (fi)
BE (1) BE799331A (fi)
CA (1) CA1041906A (fi)
DD (1) DD104027A5 (fi)
DE (1) DE2323686A1 (fi)
DK (1) DK137706B (fi)
FI (1) FI56623C (fi)
FR (1) FR2183546B1 (fi)
GB (1) GB1421964A (fi)
HU (1) HU168307B (fi)
IL (1) IL42232A (fi)
IN (1) IN139518B (fi)
NL (1) NL158388B (fi)
OA (1) OA04380A (fi)
ZA (1) ZA733188B (fi)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
BR8406921A (pt) * 1983-05-31 1985-06-04 Choong Gook Jang Composicoes secas de compressao,direta para formas de dosagem de liberacao controlada
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DK0522128T3 (da) * 1991-01-30 1996-02-26 Wellcome Found Vanddispergerbare tabletter indeholdende acyclovir
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
DE69332801T2 (de) * 1992-11-30 2004-01-29 Kv Pharm Co Geschmacksmaskierte pharmazeutische substanzen
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (fi) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
PT1685839E (pt) 1997-12-22 2013-07-08 Euro Celtique Sa Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
CN1525851A (zh) 2001-05-11 2004-09-01 ������ҩ�����޹�˾ 抗滥用阿片样物质控释剂型
CN100411611C (zh) 2002-04-05 2008-08-20 欧洲凯尔蒂克公司 用于持续,不变且独立释放活性化合物的基质
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
ES2314646T3 (es) * 2004-03-22 2009-03-16 Solvay Pharmaceuticals Gmbh Composiciones farmaceuticas por via de productos que contienen lipasa , en particular de pancreatina, que contienen tensioactivos.
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
BRPI0606339A2 (pt) * 2005-01-28 2009-06-16 Euro Celtique Sa formas farmacêuticas resistentes a álcool
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1913138B1 (en) * 2005-07-29 2016-08-24 Abbott Laboratories GmbH Processes for the manufacture of pancreatin powder with low virus content
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
BRPI0910780A2 (pt) * 2008-07-07 2016-08-09 Euro Celtique Sa uso de antagonistas de opióides para o tratamento da retenção urinária
NZ595663A (en) 2009-03-10 2013-11-29 Euro Celtique Sa Immediate release pharmaceutical compositions comprising oxycodone and naloxone
CA2918004C (en) 2013-07-23 2018-11-20 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Also Published As

Publication number Publication date
FR2183546A1 (fi) 1973-12-21
AU5531473A (en) 1974-11-07
GB1421964A (en) 1976-01-21
HU168307B (fi) 1976-03-28
DE2323686A1 (de) 1973-11-22
FI56623C (fi) 1980-03-10
IL42232A (en) 1976-08-31
NL158388B (nl) 1978-11-15
CA1041906A (fr) 1978-11-07
JPS5526124B2 (fi) 1980-07-11
US3950508A (en) 1976-04-13
ZA733188B (en) 1975-01-29
DK137706B (da) 1978-04-24
JPS4992217A (fi) 1974-09-03
DD104027A5 (fi) 1974-02-20
OA04380A (fr) 1980-02-15
AR203268A1 (es) 1975-08-29
BE799331A (fr) 1973-11-09
NL7306422A (fi) 1973-11-13
IL42232A0 (en) 1973-07-30
DK137706C (fi) 1982-11-15
IN139518B (fi) 1976-06-26
FR2183546B1 (fi) 1975-06-20

Similar Documents

Publication Publication Date Title
FI56623B (fi) Saett att framstaella oralt intagbara medicinformer med foerlaengd verkan
FI56822B (fi) Foerfarande foer att omvandla glukos till glukonsyra
FI54994B (fi) Engaongsbloeja med tejpfaestning
FI53341C (fi) Kombinerad takraenne/takfotsenhet
FI55733C (fi) Anordning foer tvinnande av tvinnelement foer elkablar till en tvinnad enhet med avsnittsvis skiftande skruvningsriktning
FI54940B (fi) Saett att framstaella cellulosamassa med hoeg ljushet
FI56127C (fi) Saett att behandla avgaser innehaollande olika svavelfoereningar
FI55067C (fi) Saett att tillvarataga koklut
FI55061C (fi) Saett att framstaella cellulosamassa medelst syrgasdelignifiering
FI55734B (fi) Foerfarande foer tvinnande av en elkabels tvinnelement till en tvinnad enhet med avsnittsvis omvaexlande skruvningsriktning
FI55755B (fi) Foerfarande foer framstaellning av en koagulerad mjoelkprodukt med ultrafiltrering
FI55417C (fi) Minnesanordning med reservminneselement
FI54500B (fi) Icke-elektrisk belaeggning med koppar
FI56910B (fi) Anslutningslist med oeverspaenningsskyddsanordning
FI56101C (fi) Belagd norbornen-rodenticidkomposition
AT322166B (de) Bauelement
FI56555B (fi) Saett att legera staol med vanadin
TR17253A (tr) Herbisid bilesim
TR17697A (tr) Herbisid bilesimi
IT981480B (it) Benzimidazoli sostituiti
FI54910C (fi) Saett att nyttiggoera roekgas- eller filterstoft
FI56559B (fi) Garnkrusningsapparat med krusningskammare
FI54061B (fi) Saett att minska totalmaengden av svavel i claus-avgaser
BR7200652D0 (pt) Arranjo disponivel
AR192453A1 (es) Conjunto de microtitulacion